News
CEO Emma Walmsley’s 40-bln-pound 2031 sales target looks fanciful after another disappointing drug trial. A healthy balance ...
General Mills faces Q4 declines in sales and EPS amid shifting consumer habits. FY2026 guidance is mixed: sales are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results